Interactions between proteins and heparin(-like) structures involve el
ectrostatic forces and structural features. Based on charge distributi
ons in the linear sequence of protein C inhibitor (PCI), two positivel
y charged regions of PCI were proposed as possible candidates for this
interaction. The first region, the A(+) helix, is located al the N-te
rminus (residues 1-11), whereas the second region, the H helix, is pos
itioned between residues 264 and 280 of PCI. Competition experiments w
ith synthetic peptides based on the sequence of these regions demonstr
ated that the H helix has the highest affinity for heparin. In contras
t to previous observations we found that the A(+) helix peptide compet
ed for the interaction of PCI with heparin, but its affinity was much
lower than that of the H helix peptide. Recombinant PCI was also used
to investigate the role of the A(+) helix in heparin binding. Full-len
gth (wild-type) rPCI as well as an A(+) helix deletion mutant of PCI (
rPCI-Delta 2-11) were expressed in baby hamster kidney cells and both
had normal inhibition activity with activated protein C and thrombin.
The interaction of the recombinant PCIs with heparin was investigated
and compared to plasma PCI. The A(+) helix deletion mutant showed a de
creased affinity for heparin in in hibition reactions with activated p
rotein C and thrombin, but had similar association constants compared
to wild-type rPCI. The synthetic A(+) helix peptide competed with rPCI
-Delta 2-11 for binding to heparin. This indicated that the interactio
n between PCI and heparin is fairly non-specific and that the interact
ion is primarily based on electrostatic interactions. In summary, our
data suggest that the H helix of PCI is the main heparin binding regio
n of PCI, but the A(+) helix increases the overall affinity for the PC
I-heparin interaction by contributing a second positively charged regi
on to the surface of PCI.